This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monday's Small-Cap Winners & Losers

Radiation Therapy Services (RTSX) was among the biggest small-cap winners Monday as the sector enjoyed a midafternoon surge along with the major indices.

Shares of the Fort Myers, Fla., company skyrocketed 43.3% on late Friday's announcement that Vestar Capital Partners agreed to buy it out for $32.50 a share, or $1.1 billion including debt assumption. The deal should close in the first quarter.

Shares gained $9.34 to $30.90 in support of the Russell 2000, which lately leapt 1.2% to 808.24.

RadiSys (RSYS - Get Report) helped fire up both the Russell 2000 and the S&P SmallCap 600 -- the latter recently up 0.9% -- after Cantor Fitzgerald stamped a buy rating on the Oregon-based computer-systems maker. The analyst cited strong earnings at key customer Nokia-Siemens, among other things. RadiSys shares traded 15.8% higher at $13.57.

PetMed Express (PETS - Get Report), or 1-800-PetMeds, saw climbing fiscal second-quarter income of 18 cents a share on revenue that shot up 17.6% to a slightly better-than-expected $51.5 million. Analysts were looking for 17 cents a share, excluding special items; last year the Florida pet-medications purveyor made 14 cents a share. Petmed stock was up 84 cents, or 6.1%, to $14.68.

Elsewhere, management-and-consulting firm China Direct (CDS) boosted its full-year earnings guidance to more than $9.5 million from the prior $8.25 million. The Boca Raton, Fla., company also padded its revenue outlook by at least $25 million for a new outlook of more than $175 million. Shares were up 19.1% to $9.93.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MINI $32.25 0.00%
PLUG $2.06 0.00%
PETS $18.30 0.00%
RSYS $4.46 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs